EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Time of Day-Dependent Responses to Cisplatin Treatment in a Male Mouse Model of Hepatoma

Yasemin Kubra Akyel, Christopher P Selby, Aziz Sancar, Ashraf N Abdo iD

Journal of Biological Rhythms · 2025

DOI: 10.1177/07487304251349893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Rhythms, 2025. Verfasst von Yasemin Kubra Akyel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Cisplatin, Carcinoma, Hepatocellular, Circadian Rhythm, Antineoplastic Agents. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS, NIGMS NIH HHS, Common Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The circadian clock maintains oscillations in gene expression with a 24-hour periodicity in nearly every cell of the body and confers rhythmic patterns to many aspects of behavior and physiology. The presence of circadian rhythms in tumors leads to the question of whether tumors may respond differently to chemotherapy given at different times of day. We addressed this question using a male mouse model of hepatoma by treating mice in the morning (ZT2) or evening (ZT14) with cisplatin, and measuring gross effects on body weight, blood counts and chemistry, gene expression, and cellular proliferation. We found that among cisplatin-treated mice, there was a reduction in expression of the proliferation marker protein Ki-67 in tumors of mice treated at ZT14 as compared to ZT2. Corresponding hepatotoxicity, as measured by elevated serum alanine aminotransferase (ALT), and body weight loss were also reduced at ZT14. Overall gene expression at ZT14 was more similar to healthy liver than expression at ZT2. Mitogen-activated protein kinase (MAPK) and Ras-related protein-1 (Rap-1) signaling pathways were specifically downregulated in tumors following treatment at ZT14, which may be related to the decreased proliferation, at this treatment time. These findings align with the possible use of timed chemotherapy to enhance drug efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinCarcinoma, HepatocellularCircadian RhythmAntineoplastic AgentsLiver NeoplasmsAnimalsMaleMiceCell ProliferationDisease Models, AnimalBody WeightMice, Inbred C57BLGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

DNA damageanticancer drugcarcinogenesiscircadian rhythmscisplatinliver cancertumor therapy

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Medical Pharmacology, School of Medicine, Istanbul Medipol University, Istanbul, Türkiye.

ORCID-Profile: Ashraf N Abdo

Förderung

  • NIEHS NIH HHS
  • NIGMS NIH HHS
  • Common Fund

Zitieren

APA

Akyel, Y. K., Selby, C. P., Sancar, A., & Abdo, A. N. (2025). Time of Day-Dependent Responses to Cisplatin Treatment in a Male Mouse Model of Hepatoma. Journal of Biological Rhythms. https://doi.org/10.1177/07487304251349893

Vancouver

Akyel YK, Selby CP, Sancar A, Abdo AN. Time of Day-Dependent Responses to Cisplatin Treatment in a Male Mouse Model of Hepatoma. Journal of Biological Rhythms. 2025. doi:10.1177/07487304251349893

BibTeX
@article{Akyel2025,
  author = {Akyel, Yasemin Kubra and Selby, Christopher P and Sancar, Aziz and Abdo, Ashraf N},
  title = {Time of Day-Dependent Responses to Cisplatin Treatment in a Male Mouse Model of Hepatoma},
  journal = {Journal of Biological Rhythms},
  year = {2025},
  doi = {10.1177/07487304251349893}
}
Kostenlos starten →